Ticker brief
MEDS
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
15
authors 14d
10
crowd 14d
+0.1σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-16 · now +0.10 (−1 bearish … +1 bullish)
Who spoke10
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @AccesswireNews | C | · | 3 | +0.20 |
| @CrweWorld | C | · | 2 | +0.00 |
| @smith_will86715 | C | -3.74 | 2 | +0.05 |
| @MrGannabc | C | -1.55 | 2 | +0.70 |
| @KeithMcCullough | A | -3.03 | 1 | -0.35 |
| @dmdt14 | C | -0.48 | 1 | +0.30 |
| @StockSwingAlert | C | -1.17 | 1 | +0.45 |
| @BankTheTrade | C | -0.03 | 1 | +0.50 |
| @doublejtrading | C | +1.73 | 1 | +0.00 |
| @Greatstockpix | C | -1.40 | 1 | +0.00 |
Recent signals15of 15 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @AccesswireNews | +0.10 | DataMeds commented positively on a proposed FDA interim-access policy. | · | tweet ↗ |
| 2026-10-13 | @CrweWorld | +0.00 | DataMEDS provides a business update on its laboratory and oncology division | · | tweet ↗ |
| 2026-10-13 | @AccesswireNews | +0.00 | DataMEDS announces a business update concerning its laboratory and predictive-oncology division. | · | tweet ↗ |
| 2026-10-12 | @MrGannabc | +0.60 | Posts a multi-stock recap of large realized or claimed gains and targets hit. | · | tweet ↗ |
| 2026-10-12 | @Greatstockpix | +0.00 | Morning gapper watchlist without directional trade intent. | · | tweet ↗ |
| 2026-10-12 | @doublejtrading | +0.00 | Publishes a premarket gapper list; extraction is capped at the first six tickers. | · | tweet ↗ |
| 2026-10-12 | @BankTheTrade | +0.50 | Reports Medicaid coverage determination for Helomics' ChemoFx assay in gynecologic cancers. | · | tweet ↗ |
| 2026-10-12 | @StockSwingAlert | +0.45 | Provides watch levels and breakout thresholds for VCIG and MEDS without clear entry intent. | · | tweet ↗ |
| 2026-10-12 | @MrGannabc | +0.80 | Celebrates MEDS reaching three prior targets and $4.68. | · | tweet ↗ |
| 2026-10-12 | @AccesswireNews | +0.50 | Helomics receives Medicaid coverage policy for its ChemoFx assay in gynecologic cancers. | · | tweet ↗ |
| 2026-10-12 | @dmdt14 | +0.30 | MEDS is placed on today's watch list conditional on holding 2.80 support. | · | tweet ↗ |
| 2026-10-08 | @smith_will86715 | +0.00 | Claims a short squeeze has begun in nano-float SHFS and cites prior comparables. | · | tweet ↗ |
| 2026-10-08 | @smith_will86715 | +0.10 | Author expects SHFS to become a top runner today and cites its float and deposits | · | tweet ↗ |
| 2026-10-07 | @KeithMcCullough | -0.35 | Wordplay implies retail enthusiasm or participation in MEDS has faded. | · | tweet ↗ |
| 2026-10-05 | @CrweWorld | +0.00 | Datameds reports DBA filings and reminds shareholders about a meme-coin payment record date. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.